Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib

Leukemia. 2022 May;36(5):1448. doi: 10.1038/s41375-022-01568-3.

Authors

Yuya Sasaki¹, Hagop M Kantarjian¹, Nicholas J Short¹, Feng Wang², Ken Furudate^{1

3}, Hidetaka Uryu¹, Rebecca Garris¹, Nitin Jain¹, Koji Sasaki¹, Farhad Ravandi¹, Marina Konopleva¹, Guillermo Garcia-Manero¹, Latasha Little², Curtis Gumbs², Li Zhao², P Andrew Futreal², Koichi Takahashi^{1

2}, Elias Jabbour⁴

Affiliations

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
⁴ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ejabbour@mdanderson.org.

PMID: 35411096
DOI: 10.1038/s41375-022-01568-3

No abstract available

Publication types

Published Erratum